Reports

• High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

  

• Advisory Opinion 21-12

  

• An Ophthalmology Clinic in Florida: Audit of Medicare Payments for Eye Injections of Avastin, Eylea, and Lucentis

  

• Colorado Did Not Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations

  

• CMS COVID-19 Data Included Required Information From the Vast Majority of Nursing Homes, but CMS Could Take Actions To Improve Completeness and Accuracy of the Data

  

• Medicare Beneficiaries Hospitalized With COVID-19 Experienced a Wide Range of Serious, Complex Conditions

  

• Oklahoma Oversight of Medicaid Outpatient Services for Opioid Use Disorder Was Generally Effective

  

• Medicare Home Health Agency Provider Compliance Audit: Catholic Home Care

  

• Advisory Opinion 21-11

  

• Medicare Hospital Provider Compliance Audit: Jewish Hospital

  

• CGS Administrators, LLC, Claimed Some Unallowable Medicare Pension Costs Through Its Incurred Cost Proposals

  

• CGS Administrators, LLC, Claimed Some Unallowable Medicare Supplemental Executive Retirement Plan III Costs Through Its Incurred Cost Proposals

  

• Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the First Quarter of 2021

  

• Medicare Paid New Hospitals Three Times More for Their Capital Costs Than They Would Have Been Paid Under the Inpatient Prospective Payment System

  

• Missouri Claimed Federal Reimbursement for $3.4 Million in Payments to Health Home Providers That Did Not Meet Medicaid Requirements

  

• Companion Data Services, LLC, Claimed Some Unallowable Medicare Excess Plan Costs Through Its Incurred Cost Proposals

  

• Medicare Continues To Make Overpayments for Chronic Care Management Services, Costing the Program and Its Beneficiaries Millions of Dollars

  

• Advisory Opinion 21-10

  

• State Backlogs of Standard Surveys of Nursing Homes Grew Substantially During the COVID-19 Pandemic

  

• New York Improperly Claimed $439 Million In Medicaid Funds for Its School-Based Health Services Based on Certified Public Expenditures